Morgan Stanley set a €91.00 ($95.79) price objective on Sanofi SA (EPA:SAN) in a research note released on Tuesday morning. The brokerage currently has a buy rating on the stock.

Other equities research analysts also recently issued reports about the stock. Kepler Capital Markets set a €89.00 ($93.68) price target on shares of Sanofi SA and gave the company a buy rating in a research note on Thursday, August 11th. JPMorgan Chase & Co. set a €71.00 ($74.74) target price on shares of Sanofi SA and gave the stock a sell rating in a research note on Thursday, September 15th. Jefferies Group set a €76.00 ($80.00) target price on shares of Sanofi SA and gave the stock a neutral rating in a research note on Tuesday, September 13th. Berenberg Bank set a €93.00 ($97.89) target price on shares of Sanofi SA and gave the stock a buy rating in a research note on Thursday, September 8th. Finally, Societe Generale set a €100.00 ($105.26) target price on shares of Sanofi SA and gave the stock a buy rating in a research note on Monday, August 1st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company. Sanofi SA currently has a consensus rating of Hold and an average price target of €84.00 ($88.42).

Analyst Recommendations for Sanofi SA (EPA:SAN)

Sanofi SA (EPA:SAN) opened at 76.47 on Tuesday. The stock has a market cap of €98.42 billion and a PE ratio of 23.46. The firm has a 50 day moving average of €25.50 and a 200-day moving average of €25.74. Sanofi SA has a 12-month low of €62.50 and a 12-month high of €84.81.

COPYRIGHT VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was illegally copied and republished in violation of U.S. & international copyright laws. The correct version of this report can be accessed at https://www.thecerbatgem.com/2016/11/30/sanofi-sa-san-given-a-91-00-price-target-at-morgan-stanley.html.

About Sanofi SA

Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.

Receive News & Stock Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related stocks with our FREE daily email newsletter.